Policy changes and the screening, diagnosis and treatment of drug-resistant tuberculosis patients from 2015 to 2018 in Zhejiang Province, China: a retrospective cohort study.
Weixi JiangYing PengXiaomeng WangChris ElbersShenglan TangFei HuangBin ChenFrank CobelensPublished in: BMJ open (2021)
The policy changes on DST and registration have effectively improved DRTB case finding and care. Nevertheless, challenges remain in servicing vulnerable groups such as migrants and improving equity in the access to TB care. Future policies should provide comprehensive support for migrants to complete treatment at their current place of residence.
Keyphrases
- drug resistant
- healthcare
- public health
- multidrug resistant
- mycobacterium tuberculosis
- palliative care
- end stage renal disease
- acinetobacter baumannii
- mental health
- newly diagnosed
- ejection fraction
- chronic kidney disease
- quality improvement
- pain management
- emergency department
- affordable care act
- global health
- pseudomonas aeruginosa
- combination therapy
- hepatitis c virus
- health insurance
- hiv aids